Remind yourself of the monitoring requirements for disease-modifying antirheumatic drugs with the MIMS DMARDs table.
This table summarises the ongoing tests advised for patients taking the DMARDs azathioprine, chloroquine, ciclosporin, hydroxychloroquine, leflunomide, methotrexate, penicillamine, sodium aurothiomalate (gold) or sulfasalazine.
- full blood counts
- liver function tests
- ophthalmological examination
- renal function and urinalysis
- blood pressure
- serum lipids
- chest x-ray
- plasma drug levels
The recommended frequency of testing is also noted in the table.
Brand names link through to the full MIMS entries for more detailed prescribing information on each product.